“Randomized trials - Ivermectin repurposing for COVID-19 treatment of outpatients with mild disease in primary health care centers”, RSD, vol. 11, no. 8, p. e35511830844, Jun. 2022, doi: 10.33448/rsd-v11i8.30844.